OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Cardiology is 4. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-09-01 to 2025-09-01.)

Article	Citations
Advances in device-based therapies for cardiorenal syndrome	33
Device therapy for heart failure management	22
Editorial: from albuminuria to uric acid – emerging risk factors beyond lipids	19
Genetics of sudden cardiac death	19
Assessment and management of neonates with unrepaired congenital heart disease	17
Editorial introductions	15
Role of medical management of cardiogenic shock in the era of mechanical circulatory support	15
Vascular regenerative cells in cardiometabolic disease	14
Persistent inflammatory residual risk despite aggressive cholesterol-lowering therapy: what is next?	13
Pemafibrate and other triglyceride-lowering therapies to reduce risk of cardiovascular and metabolic disease	13
REVIVED BCIS-2: update and key learnings	13
The role of artificial intelligence in early detection and intervention of coronary artery disease	12
Low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol and apolipoprotein B for cardiovascular care	12
Editorial introductions	12
Epigenetic remodeling in heart failure with preserved ejection fraction	11
Cardiac phenotypes in LMNA mutations	11
Clinical considerations and pathophysiological associations among obesity, weight loss, heart failure, and hypertension	11
Team-based strategies to prevent heart failure	11
Editorial introductions	11
Cryoballoon atrial fibrillation ablation experience in Japan	11
Donation after circulatory determination of death in heart transplant: impact on current and future allocation policy	11
Multimodality cardiovascular imaging in hypertension	10
Radiofrequency lesion formation prediction with contact force versus local impedance	10
Cardiac selectivity in pulsed field ablation	10
Imaging of left ventricular outflow tract obstruction in hypertrophic cardiomyopathy	10

The impact of transcatheter edge-to-edge repair on mitral valve annular geometry	10
Recent clinical trials in atrial fibrillation	10
Coronary artery bypass grafting in low ejection fraction: state of the art	9
Wellness and burnout in cardiac surgery: not black and white	9
Challenges in diagnosis and management of coarctation of the aorta	9
Management of hypertension in heart transplant recipients: an ongoing conundrum	8
Near infrared spectroscopy in the pediatric cardiac intensive care unit: accurately interpreting the data	8
Editorial introductions	7
Expanding revascularization trials to women and underserved minorities and shifting to patient-centered outcomes: RECHARGE trials program	7
The mitral valve in hypertrophic cardiomyopathy	7
Weight loss and atrial fibrillation: a review	7
Sleep apnea and cardiovascular risk	7
Is the world ready for the STICH 3.0 trial?	7
Integration of palliative care across the spectrum of heart failure care and therapies: considerations, contemporary data, and challenges	7
Bicuspid aortic valve associated aortopathy: 2022 guideline update	7
Impact of glucagon-like peptide-1 receptor agonists on hypertension management: a narrative review	7
Management of difficult coronary anatomy during transcatheter aortic valve implantation: what are the key issues?	7
Electrographic flow mapping of atrial fibrillation	6
New wrinkles in hypertension management 2022	6
Bad behavior in healthcare: an insidious threat to patients, staff, and organizations	6
Editorial introductions	6
Catheter-based therapies in acute and chronic pulmonary embolism	6
Factor XI inhibitors: what should clinicians know	6
The pleiotropic cardiovascular effects of sodium-glucose cotransporter-2 inhibitors	6
Current and future transcatheter aortic valve replacement valves	6
Promoting gender diversity and ergonomic equity in the cardiac surgery operating room	6
Albuminuria and cardiorenal risk	6
Coronary microvascular dysfunction and heart failure with preserved ejection fraction: what are the mechanistic links?	6
Update on the molecular landscape of thoracic aortic aneurysmal disease	6
Editorial introductions	5
Editorial introductions	5
Long noncoding RNAs in cardiovascular disease	5
Disparity issues in coronary artery surgery	5
Improving diversity in cardiac surgery clinical trials with ROMA:Women as an exemplar	5
Clinical trials of cell therapy for heart failure: recent results warrant continued research	5
A tale of two balloons: technical and procedural difference between cryoballoon systems	5
Destination LVAD therapy in the current era of the heart transplant allocation system	5
Peripheral arterial disease and hypertension	5
When should the tricuspid valve be repaired during mitral valve repair?	5
Robotic mitral valve surgery: evolving history, techniques, and training paths	5
Electronic health strategies to improve medication adherence in patients with cardiometabolic disease: current status and future directions	5
The management of new-onset atrial fibrillation in critical illness: an update on current therapeutic options	4
Left main revascularization guidelines: navigating the data	4
Influenza vaccination in mitigating vascular events and risk	4
Statin-Associated muscle symptoms and vitamin D supplementation	4
Editorial introductions	4
Editorial: the year in lipids and emerging risk factors	4
Semaglutide for weight loss and cardiometabolic risk reduction in overweight/obesity	4
How to deal with nonsevere stenoses in coronary artery bypass grafting – a critical perspective on competitive flow and surgical precision	4
Clinical impact of genetic testing for lipid disorders	4

Coronary artery calcium and sudden cardiac death: current evidence and future directions	4
Management of pregnancy in left ventricular assist device and heart transplant recipients: a concise review	4
Double outlet right ventricle – the 50% rule has always been about the conus	4
Building resilient heart center teams	4
Ischemic mitral regurgitation: when should one intervene?	4
Artificial sweeteners and cardiovascular risk	4
Mitral valve surgery after failed transcatheter edge-to-edge repair: a review and word of caution	4
High lipoprotein(a) is a risk factor for peripheral artery disease, abdominal aortic aneurysms, and major adverse limb events	4
Arrhythmogenic right ventricular cardiomyopathy in the pediatric population	4
Brugada syndrome – minimizing overdiagnosis and over treatment in children	4
The landscape of cardiogenic shock: epidemiology and current definitions	4